AFI Ventures is the seed fund of Alliance for Impact, Europe's day one impact launchpad. AFI Ventures invests in impact-driven startups reimagining every sector of the economy in a fairer and more sustainable way. We are on a mission to finance up to 2 companies per month with 100K-500K€ pre-seed/seed tickets.

AFI Ventures

Kima Ventures is one of the world's most active early-stage investors, investing in 2 to 3 startups per week all over the world; providing founders with funding, network, and support for them to reach the next steps of their journey. The firm invests from seed to Series A, mostly as lead investor but also working alongside other investors; backing ambitious founders who work hard to build awesome things that more and more people use everyday. The company helps them to build a great team, to learn very quickly, to keep the right focus and execute towards growth. Kima takes pride of itself in working side-by-side with entrepreneurs. They claim to understand that fundraising is only one step in the company’s journey, that’s why they take quick decisions and make the fundraising process as smooth as possible so the founders can get back to the work of building their business. Kima considers itself not only an investor, but a network of founders and experts sharing a pay it forward mindset. Headquartered in Paris with an office in London, the company was founded and backed by Xavier Niel, founder of Iliad and supporter of entrepreneurs through such projects as 42, Station F and 101projets. Over the last 5 years Kima has invested in over 400 startups in 24 different countries.

Kima Ventures

Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow. We want to become the closest partner of our portfolio companies by working together on key strategic decisions and operative challenges. As a privately financed venture capital investor with long-term and flexible capital we are looking for exceptional founders who are committed to building category leaders throughout the next 5-10+ years. We invest in early-stage technology ventures with a focus on financial services, HR, energy & climate, healthcare, logistics & mobility, real estate & construction, crypto & web3, deeptech and e-commerce. Picus makes initial investments in pre-seed, seed and series A ventures thereby starting to work together with entrepreneurs in various stages of their companies ranging from ideation phase to initial traction. We follow a very long-term investment approach investing significant amounts throughout the lifecycle of the companies. We have invested in over 50 companies to date. At Picus we work in a culture combining the discipline of a financial investor with the creativity and pragmatism of an entrepreneur. We follow a comprehensive and well-structured investment approach in order to identify the most attractive and ambitious investment opportunities in our target industries and geographies. Within our core investment team every member has a distinctive industry competence and a functional or geographic focus. We are working closely together with our portfolio companies to develop large and successful market leaders. This comprises in particular leveraging our marketing & sales expertise and our global market perspective to provide strategic advice, providing HR management to grant access to top talent, connecting our portfolio companies with our broad B2B & investor network as well as supporting the fundraising process.

Picus Capital

Founders Future is a venture capital investment firm that seeks to invest in startups to later-stage companies focusing on the commercial services, commercial products, and software sectors.

Founders Future

High Flyers Capital is a venture capital firm that seeks to invest in the food and beverage sector.

High Flyers Capital

Exceptional Ventures is an early-stage venture capital firm that invests in entrepreneurs and businesses that improve people's lives. Founded in 2022 and is based in London, England.

Exceptional Ventures

Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed to later-stage. The firm manages over €2 billion of assets dedicated to life science investing and actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact its collective future. It invests in start-ups, early-stage companies, corporate spin-offs, and occasionally turnaround situations with a focus on Life Sciences (Biopharmaceuticals / Biotech, Medical Devices, Industrial Biotechnology). Sofinnova Partners proactively sources deals, takes a lead role, is most often the first institutional investor in Round A financings, and leads its portfolio companies until exit. They sit on the boards of their portfolio companies and play an active role from the formation phase alongside entrepreneurs. It was headquartered in Paris, Ile-de-France in 1972.

Sofinnova Partners

CapTech was formed as the result of a friendship between the company's founders, Sandy Williamson and Slaughter Fitz-Hugh, that began while both were employed at Andersen Consulting in Washington, D.C. Eventually, each would leave the company to pursue other opportunities, but they stayed in touch. In March of 1997, the two found themselves back in their shared hometownâ€”Richmond, Virginiaâ€”and this close proximity led to the creation of CapTech Ventures, Inc., an exceptional business partnership.  The company has been successful from the very beginning, growing from $380,000 in revenue the first year to millions today. Always a privately held company, CapTech has thrived without the support of outside investors funding. Through partnership with clients and by providing exceptional service, CapTech has continued to grow and build on its successes. Now a full service information technology consultancy and the largest private IT-focused company headquartered in the region, CapTech performs services for a diverse and growing client base.

CapTech

Sparkfood is a long-term equity investor that supports the fields of ingredients and finished food goods.

Sparkfood

Capital

Bon Vivant

A French biotechnology startup founded by Hélène Briand, and Stéphane Mac Millan that leverages precision fermentation technology to develop plant-based milk using yeast to create non-dairy alternatives that are similar in texture and taste to its counterparts.

Founded in 2021, Bon Vivant is a French biotech startup that uses precision fermentation technology to develop non-dairy milk by using yeast. The company is still at the initial lab development stage and have successfully created a milk protein. The founding members of the company are on the lookout for potential strategic partnerships, costing for scale up efforts and possible funding rounds for the future.

A booming food and beverage segment with a history as rich and varied as its present-day product offerings

Plant-based Dairy & Egg

Founded in 2021, Bon Vivant is a French biotech startup that uses precision fermentation technology to develop non-dairy milk by using yeast. The company is still at the initial lab development stage and have successfully created a milk protein. The founding members of the company are on the lookout for potential strategic partnerships, costing for scale up efforts and possible funding rounds for the future.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/10993">June 2022 </a>the company signed a strategic partnership with Abolis Biotechnologies to mass produce precision fermented animal-free dairy.Funding and financialsIn its latest funding round in <a href="https://sp-edge.com/updates/22669">October 2023 </a>, Bon Vivant raised EUR 15 million (~USD 15.9 million) in seed funding led by Sofinnova Partners and Sparkfood, with participation from Captech Santé, Alliance for Impact, High Flyers Capital, and others. The funds were earmarked for scaling production capacity, obtaining regulatory clearances, and opening a new lab.

Eat JUST (Hampton Creek before 2018) is a food technology company that specializes in egg and meat alternatives. It has large-scale facilities in Germany and North America and in <a href="https://sp-edge.com/updates/9243">March 2022</a>, the company announced the groundbreaking of its new manufacturing facility in Singapore. It is the largest of its kind in the country post-completion and was slated to be completed in two years at a cost of USD 120 million.Launched in 2018, the company’s plant-based egg, JUST Egg, is made from mung beans and legumes. It offers an egg alternative for sweet and savory applications, including omelets, scrambled eggs, pancakes, and baked goods. In January 2020, the company announced a new folded plant-based egg, along with an upgrade to its original liquid plant-based egg. In <a href="https://sp-edge.com/updates/9599">April 2022</a>, the company received exclusive regulatory approval from the European Commission for its mung bean protein, a key ingredient in its JUST Egg product. In <a href="https://sp-edge.com/updates/30018">June 2024</a>, JUST Egg debuted the latest addition to its plant-based egg lineup, JUST Egg v5, featuring an improved formulation, taste, and texture.As of February 2024, JUST Egg had sold the equivalent of 500 million eggs and was available at food service outlets, online markets, and major retailers like Whole Foods, Sprouts, Walmart, Target, and Kroger.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/10634">May 2022</a>, tennis pro Serena Williams and renowned actor Jake Gyllenhaal partnered with the company to appear in its national ad campaign “Really Good Eggs” to promote JUST Egg. In <a href="https://sp-edge.com/updates/13770">October 2022</a>, the company partnered with MingsBings to launch four new vegan breakfast items featuring JUST Egg. Also, during the same month, JUST Egg <a href="https://sp-edge.com/updates/13795">partnered</a> with Starbucks for a limited trial of new vegan menu items. In <a href="https://sp-edge.com/updates/20178">July 2023</a>, the company partnered with Alpha Foods as a part of its brand portfolio renovation. Following this, JUST Egg <a href="https://sp-edge.com/updates/21095">partnered</a> with Korean alternative meat company UNLIMEAT to develop Korean-style vegan products.Funding and financialsIn <a href="https://sp-edge.com/updates/12427">August 2022</a>, the company bagged a USD 25 million investment along with a strategic partnership from Alibaba-Group-backed private equity firm, C2 Capital Partners. Together, the companies are set to work towards expanding Eat Just’s footprint in the Chinese market. Later, in <a href="https://sp-edge.com/updates/21471">September 2023</a>, the company raised an undisclosed amount in new funding led by VegInvest/Ahimsa Foundation. The funding was to be deployed towards improving the quality and profitability of Eat JUST's products.

Eat JUST

Zero Egg is an Israel-based developer of egg alternatives in powder form using plant-based ingredients such as soy, potatoes, peas, and chickpeas. The startup initially launched two main products, the EGG Basic, a replacement for scrambled eggs and omelets, and BAKE Basic, an egg replacement for baking. In <a href="https://sp-edge.com/updates/13217">September 2022 </a>, the company launched “Zero Egg Scoopable Scramble”, a ready-to-eat frozen plant-based scrambled egg product claimed to be the world’s first of its kind.The company initially only sold to foodservice customers and food manufacturers in 2 lb. bags of around 86 to 130 equivalent eggs. In October 2020, Zero Egg entered the US B2B market following a successful launch in the Netherlands and Israel. As of March 2024, the company’s products can also be purchased online in Patty and Liquid form.In 2021, the company announced that its product is co-manufactured in Cookeville, Tennessee, and would be distributed by Gordon Food Service in the US in 2021.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/18573">May 2023 </a>, Zero Egg partnered with NYC’s Plantega to become the latter’s exclusive plant-based egg supplier. Plantega, based on a deli-in-store concept, featured Zero Egg’s new Egg Patty in its bodega-style breakfast sandwiches, available via all its outlets and food delivery platforms. The following month, the company <a href="https://sp-edge.com/updates/19335">partnered with The Friendly Toast </a>, a US restaurant chain, to launch the Vegan Zero Egg Breakfast Sandwich at all of its ten locations.Funding and financialsIn November 2020, the company raised USD 5 million in a Series A funding round led by Powerplant Ventures. The funding was earmarked for new product launches and expanding the company’s US footprint.

Zero Egg

Perfect Day produces animal-free dairy products using fermentation techniques. The startup uses microflora (microorganisms such as bacteria, yeast, or in this case, fungi) to create the protein blocks of milk-casein and whey via fermentation, which is later combined with fat and water to produce genetically identical substitutes to animal milk. Perfect Day has developed the microflora to produce milk proteins with a similar genetic blueprint corresponding to casein and whey. The startup launched its first product in 2019, a limited line of animal-free ice cream. Perfect Day has also developed animal-free substitutes for cream cheese, feta, and cheese spreads, in addition to milk. Since its first funding round in December 2019, Perfect Day reported a doubling of production capacity while significantly reducing costs. In <a href="https://sp-edge.com/updates/14938">November 2022</a>, the company launched its Very Dairy animal-free milk in Singapore which is claimed to be the first precision fermented milk to enter the Asian market. Following this, Perfect Day <a href="https://sp-edge.com/updates/14989">acquired India’s Sterling Biotech Limited </a>at a value of 638 crore rupees (~USD 78 million). In <a href="https://sp-edge.com/updates/32960">August 2024</a>, 50% of Perfect Day’s stake in Sterling Biotech was acquired by Indian pharmaceutical company Zydus Lifesciences.In <a href="https://sp-edge.com/updates/20068">July 2023</a>, Perfect Day exited its consumer-facing business, The Urgent Company (TUC), due to investor pressure and to shift its focus towards R&amp;D innovation, B2B partnerships, and its nth Bio precision fermentation consulting business. 15% of the workforce at TUC was laid off as a part of this move.Key customers and partnershipsThe company entered into partnerships with Tomorrow Farms in <a href="https://sp-edge.com/updates/10605">May 2022 </a>and Strive Nutrition in <a href="https://sp-edge.com/updates/10862">June 2022 </a>to supply fermented animal-free whey protein for the production of alternative milk. In <a href="https://sp-edge.com/updates/11970">July 2022</a>, the company partnered with sports nutrition brand, Myprotein to launch a precision fermented Whey protein powder. The company partnered with global food and beverage leader, Nestle in <a href="https://sp-edge.com/updates/12953">September 2022 </a>to develop and trial an unnamed alternative milk beverage. Further, during the same month, the company unveiled its <a href="https://sp-edge.com/updates/13187">enterprise biology business, “nth Bio”</a>, offering precision fermentation expertise and technology to companies worldwide and announced Onego Bio as its first partner in this new venture.In <a href="https://sp-edge.com/updates/26920">February 2024</a>, Perfect Day partnered with Unilever-owned ice cream company Breyers, to supply precision-fermented whey protein for developing a lactose-free ice cream product.Funding and financialsIn its latest funding round in <a href="https://sp-edge.com/updates/25248">January 2024</a>, Perfect Day raised up to USD 90 million in pre-Series E funding led by its internal investors. The funding was earmarked for supporting Perfect Day's shift toward manufacturing on a larger scale and paving the path for the commercial release of its fermented whey protein product.

Perfect Day

Califia Farms uses almonds to produce a range of plant-based alternatives such as milk, cold-brew coffee, creamers, half-and-half, butter, and yogurt. In February 2019, the US-based startup launched Übermilk, a milk alternative made with oat milk, pea protein, sunflower oil and seeds, flaxseed oils, and other vitamins and minerals. Übermilk contains the same amount of calories, more protein (8 g), and less sugar (2 g) than a serving of cow’s milk.In <a href="https://sp-edge.com/updates/14325">November 2022</a>, Califia Farms added plant-based whipping cream to its portfolio with the launch of Heavy Whip. In <a href="https://sp-edge.com/updates/15601">January 2023</a>, the company added USDA-certified Organic Oatmilk and Almondmilk–made with only purified water, sea salt, and oats/almonds–to its alternative dairy products. Further, in <a href="https://sp-edge.com/updates/26576">February 2024</a>, the company launched Califia Farms Complete, a plant-based milk claimed to be nutritionally comparable to dairy. It followed this up by launching ‘<a href="https://sp-edge.com/updates/31054">Complete Kids</a>’, a kid-friendly version of its Complete plant-based milk.In <a href="https://sp-edge.com/updates/31925">July 2024</a>, Califia Farms acquired Uproot Inc., a company developing plant milk dispenser systems for foodservice, for an undisclosed sum. With this acquisition, the company aimed to expand its "Away From Home" portfolio and offer plant milk in a convenient dispensing solution at hundreds of colleges, universities, and other dining locations.Califia Farms products are available in the US at Whole Foods, Kroger, Sprouts, and Target outlets.Funding and financialsIn January 2020, Califia Farms raised USD 225 million in Series D funding led by the Qatar Investment Authority to expand its production capacity, R&amp;D efforts, and geographical footprint.

Califia Farms

Kite Hill manufactures a range of plant-based dairy products such as yogurt, yogurt drinks, cream cheese, ricotta, sour cream, and butter using cultured almond milk and coconut milk. Kite Hill has developed its own proprietary cultures and enzymes to create a texture and taste similar to real cheese. After mixing with the cultures and enzymes, the almond milk is left to inoculate and transform to curd and whey overnight.In 2014, Kite Hill launched its first product line, a range of plant-based cheese at Whole Foods, followed by a range of yogurts and cream cheese made from almond milk in 2015. The CEO of plant-based meat startup Impossible Foods, Pat Brown, is also a co-founder of the startup. Kite Hill products are available in Whole Foods Markets, Sprouts, Publix, Target, and Safeway/Albertsons.Funding and financialsIn its most recent funding round in September 2019, Kite Hill raised USD 10 million in funding; the company did not disclose its plan for the funds.

Kite Hill

Producers of plant-based milk alternatives using ingredients such as almonds, cashews, soy, oats, coconuts, peas, etc.

Producers of plant-based cheese alternatives using ingredients such as coconuts, almonds, cashews, soy, hazelnuts, etc. Startups use their proprietary plant-based cultures for the fermentation process

Producers of plant-based butter alternatives using ingredients such as almonds, avocados, olive oil, etc.

Producers of dairy-free ice cream using plant-based milk

Producers of dairy-free yogurt using plant-based milk and cultures

Producers of plant-based egg alternatives for general consumption (used in baking and cooking) using pulses such as mung beans, peas, soy, chickpeas, etc.

Producers of non-dairy (such as plant-based, microflora, cultured, etc.) protein bases that are supplied to dairy alternative manufacturers to produce milk, butter, cheese, ice cream, and yogurt alternatives

Provides sustainable solutions for dairy products and egg farming

DISRUPTOR_PRESENT

<div>
 <ul>
 <li>French precision fermentation startup Bon Vivant has raised EUR 15 million (~USD 15.9 million) in seed funding led by Sofinnova Partners and Sparkfood, with participation from Captech Santé, Alliance for Impact, High Flyers Capital, Kima Ventures, Founders Future, and Picus Capital.</li>
 <li>The funding will be used to scale production capacity, obtain regulatory clearances to commercialize its animal-free milk proteins and open a new lab in Lyon to develop samples for prospective clients.</li>
 <li>Bon Vivant uses biotechnology to reprogram yeast microorganisms to produce animal-free milk proteins with a lower environmental footprint than traditional dairy. The company aims to launch its milk proteins in the US market in 2025, focusing on B2B customers in the foodservice sector.</li>
 </ul>
</div>
Startup Bon Vivant has raised €15 million in seed funding led by Sofinnova Partners and Sparkfood. Other participants include Captech Santé, Alliance for Impact, High Flyers Capital, Kima Ventures, Founders Future, and Picus Capital. The funding will be used to scale production capacity, obtain regulatory clearances, and open a lab in Lyon to develop samples for clients. Bon Vivant uses biotechnology to produce animal-free milk proteins with a lower environmental impact. The company plans to launch its milk proteins in the US market by 2025, targeting B2B customers in the foodservice industry.

Bon Vivant

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless